Article
Killer-cell immunoglobulin-like receptor polymorphism is associated with COVID-19 outcome: Results of a pilot observational study.
HLA - 1 Aug 2024
Niño-Ramírez J E, Alcoceba M, Gutiérrez-Zufiaurre M N, Marcos M, Gil-Etayo F J, Bartol-Sánchez M R, Eiros R, Chillón M C, García-Álvarez M, Terradillos-Sánchez P, Presa D, Muñoz J L, López-Bernús A, López-Sánchez E, González-Calle D, Sánchez P L, Compán-Fernández O, González M, García-Sanz R, Boix F
Abstract excerpt
The pathogenesis of COVID-19 warrants unravelling. Genetic polymorphism analysis may help answer the variability in disease outcome. To determine the role of KIR and HLA polymorphisms in susceptibility, progression, and severity of SARS-CoV-2 infection, 458 patients and 667 controls enrolled in t...
Topics
- Humans
- COVID-19
- Receptors, KIR
- Male
- Female
- Middle Aged
- SARS-CoV-2
- Pilot Projects
- Retrospective Studies
- Polymorphism, Genetic
- Aged
